Publication:
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.

Simple item page
dc.contributor.authorSezer, Ahmet
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorGümüş, Mahmut
dc.contributor.authorBondarenko, Igor
dc.contributor.authorÖzgüroğlu, Mustafa
dc.contributor.authorGogishvili, Miranda
dc.contributor.authorTurk, HACI MEHMET
dc.contributor.authorCicin, Irfan
dc.contributor.authorBentsion, Dmitry
dc.contributor.authorGladkov, Oleg
dc.contributor.authorClingan, Philip
dc.contributor.authorSriuranpong, Virote
dc.contributor.authorRizvi, Naiyer
dc.contributor.authorGao, Bo
dc.contributor.authorLi, Siyu
dc.contributor.authorLee, Sue
dc.contributor.authorMcGuire, Kristina
dc.contributor.authorChen, Chieh-I
dc.contributor.authorMakharadze, Tamta
dc.contributor.authorPaydas, Semra
dc.contributor.authorNechaeva, Marina
dc.contributor.authorSeebach, Frank
dc.contributor.authorWeinreich, David M
dc.contributor.authorYancopoulos, George D
dc.contributor.authorGullo, Giuseppe
dc.contributor.authorLowy, Israel
dc.contributor.authorRietschel, Petra
dc.contributor.institutionauthorTÜRK, HACI MEHMET
dc.date.accessioned2021-02-18T20:59:06Z
dc.date.available2021-02-18T20:59:06Z
dc.date.issued2021-02-13T00:00:00Z
dc.identifier.citationSezer A., Kilickap S., Gümüş M., Bondarenko I., Özgüroğlu M., Gogishvili M., Turk H. M. , Cicin I., Bentsion D., Gladkov O., et al., -Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.-, Lancet (London, England), cilt.397, ss.592-604, 2021
dc.identifier.doi10.1016/s0140-6736(21)00228-2
dc.identifier.pubmed33581821
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28448
dc.titleCemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
dc.typeArticle
dspace.entity.typePublication
local.avesis.ide826e46a-c97b-4272-8544-9afa29e089b2
local.indexed.atPubMed
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isAuthorOfPublication.latestForDiscovery1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler